269 related articles for article (PubMed ID: 31619143)
1. Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features.
Whittall-García LP; Torres-Ruiz J; Zentella-Dehesa A; Tapia-Rodríguez M; Alcocer-Varela J; Mendez-Huerta N; Gómez-Martín D
Lupus; 2019 Nov; 28(13):1549-1557. PubMed ID: 31619143
[TBL] [Abstract][Full Text] [Related]
2. The behavior of neutrophil extracellular traps and NADPH oxidative activity in pediatric systemic lupus erythematosus: relation to disease activity and lupus nephritis.
El-Ghoneimy DH; Hesham M; Hasan R; Tarif M; Gouda S
Clin Rheumatol; 2019 Sep; 38(9):2585-2593. PubMed ID: 31030361
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of serum high-mobility group box-1 in pediatric systemic lupus erythematosus.
Hossny E; El-Ghoneimy D; Soliman DA; Ashour A
Int J Rheum Dis; 2019 Aug; 22(8):1402-1409. PubMed ID: 30938057
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus.
Zhang S; Lu X; Shu X; Tian X; Yang H; Yang W; Zhang Y; Wang G
Intern Med; 2014; 53(24):2763-71. PubMed ID: 25500436
[TBL] [Abstract][Full Text] [Related]
6. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.
Abdulahad DA; Westra J; Bijzet J; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2011 May; 13(3):R71. PubMed ID: 21548924
[TBL] [Abstract][Full Text] [Related]
7. Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis.
Zickert A; Palmblad K; Sundelin B; Chavan S; Tracey KJ; Bruchfeld A; Gunnarsson I
Arthritis Res Ther; 2012 Feb; 14(1):R36. PubMed ID: 22348591
[TBL] [Abstract][Full Text] [Related]
8. High mobility group box protein 1 (HMGB1) serum and urinary levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus: A possible relation to lupus nephritis.
Hisham FA; Tharwat S; Samra NE; Mostafa N; Nassar MK; El-Desoky MM
Lupus; 2022 Dec; 31(14):1777-1785. PubMed ID: 36214106
[TBL] [Abstract][Full Text] [Related]
9. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis.
Bruschi M; Bonanni A; Petretto A; Vaglio A; Pratesi F; Santucci L; Migliorini P; Bertelli R; Galetti M; Belletti S; Cavagna L; Moroni G; Franceschini F; Fredi M; Pazzola G; Allegri L; Sinico RA; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Ramoino P; Bianchini P; Puppo F; Pupo F; Negrini S; Mattana F; Emmi G; Garibotto G; Santoro D; Scolari F; Ravelli A; Tincani A; Cravedi P; Volpi S; Candiano G; Ghiggeri GM
J Rheumatol; 2020 Mar; 47(3):377-386. PubMed ID: 31092713
[TBL] [Abstract][Full Text] [Related]
11. Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis.
Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
Int J Rheum Dis; 2015 Jun; 18(5):533-40. PubMed ID: 25196784
[TBL] [Abstract][Full Text] [Related]
12. Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis.
Whittall-Garcia LP; Naderinabi F; Gladman DD; Urowitz M; Touma Z; Konvalinka A; Wither J
Lupus Sci Med; 2024 Jan; 11(1):. PubMed ID: 38177067
[TBL] [Abstract][Full Text] [Related]
13. [NETosis in lupus nephritis].
Reshetnyak TM; Nurbaeva KS; Ptashnik IV; Kudrieva AA; Belogurov AA; Lila AM; Nasonov EL
Ter Arkh; 2024 Jun; 96(5):453-458. PubMed ID: 38829805
[TBL] [Abstract][Full Text] [Related]
14. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
16. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
17. Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.
Koutsonikoli A; Trachana M; Farmaki E; Tzimouli V; Pratsidou-Gertsi P; Printza N; Garyphallos A; Galanopoulou V; Kanakoudi-Tsakalidou F; Papachristou F
Clin Exp Immunol; 2017 Apr; 188(1):79-85. PubMed ID: 27936517
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 Mediates NETosis and Acts as an Autoantigen in Systemic Lupus Erythematosus-Associated Diffuse Alveolar Haemorrhage.
Chen SY; Wang CT; Chen CY; Kuo PY; Wang CR; Shiau AL; Chang CH; Wu CL
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298447
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum levels of syndecan-1 are associated with renal involvement in patients with systemic lupus erythematosus.
Kim KJ; Kim JY; Baek IW; Kim WU; Cho CS
J Rheumatol; 2015 Feb; 42(2):202-9. PubMed ID: 25512478
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
